Cargando…

DNA framework-engineered chimeras platform enables selectively targeted protein degradation

A challenge in developing proteolysis targeting chimeras (PROTACs) is the establishment of a universal platform applicable in multiple scenarios for precise degradation of proteins of interest (POIs). Inspired by the addressability, programmability, and rigidity of DNA frameworks, we develop covalen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Li, Yu, Bin, Gao, Mengqiu, Chen, Rui, Li, Zhiyu, Gu, Yueqing, Bian, Jinlei, Ma, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372072/
https://www.ncbi.nlm.nih.gov/pubmed/37495569
http://dx.doi.org/10.1038/s41467-023-40244-7
_version_ 1785078289589600256
author Zhou, Li
Yu, Bin
Gao, Mengqiu
Chen, Rui
Li, Zhiyu
Gu, Yueqing
Bian, Jinlei
Ma, Yi
author_facet Zhou, Li
Yu, Bin
Gao, Mengqiu
Chen, Rui
Li, Zhiyu
Gu, Yueqing
Bian, Jinlei
Ma, Yi
author_sort Zhou, Li
collection PubMed
description A challenge in developing proteolysis targeting chimeras (PROTACs) is the establishment of a universal platform applicable in multiple scenarios for precise degradation of proteins of interest (POIs). Inspired by the addressability, programmability, and rigidity of DNA frameworks, we develop covalent DNA framework-based PROTACs (DbTACs), which can be synthesized in high-throughput via facile bioorthogonal chemistry and self-assembly. DNA tetrahedra are employed as templates and the spatial position of each atom is defined. Thus, by precisely locating ligands of POI and E3 ligase on the templates, ligand spacings can be controllably manipulated from 8 Å to 57 Å. We show that DbTACs with the optimal linker length between ligands achieve higher degradation rates and enhanced binding affinity. Bispecific DbTACs (bis-DbTACs) with trivalent ligand assembly enable multi-target depletion while maintaining highly selective degradation of protein subtypes. When employing various types of warheads (small molecules, antibodies, and DNA motifs), DbTACs exhibit robust efficacy in degrading diverse targets, including protein kinases and transcription factors located in different cellular compartments. Overall, utilizing modular DNA frameworks to conjugate substrates offers a universal platform that not only provides insight into general degrader design principles but also presents a promising strategy for guiding drug discovery.
format Online
Article
Text
id pubmed-10372072
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-103720722023-07-28 DNA framework-engineered chimeras platform enables selectively targeted protein degradation Zhou, Li Yu, Bin Gao, Mengqiu Chen, Rui Li, Zhiyu Gu, Yueqing Bian, Jinlei Ma, Yi Nat Commun Article A challenge in developing proteolysis targeting chimeras (PROTACs) is the establishment of a universal platform applicable in multiple scenarios for precise degradation of proteins of interest (POIs). Inspired by the addressability, programmability, and rigidity of DNA frameworks, we develop covalent DNA framework-based PROTACs (DbTACs), which can be synthesized in high-throughput via facile bioorthogonal chemistry and self-assembly. DNA tetrahedra are employed as templates and the spatial position of each atom is defined. Thus, by precisely locating ligands of POI and E3 ligase on the templates, ligand spacings can be controllably manipulated from 8 Å to 57 Å. We show that DbTACs with the optimal linker length between ligands achieve higher degradation rates and enhanced binding affinity. Bispecific DbTACs (bis-DbTACs) with trivalent ligand assembly enable multi-target depletion while maintaining highly selective degradation of protein subtypes. When employing various types of warheads (small molecules, antibodies, and DNA motifs), DbTACs exhibit robust efficacy in degrading diverse targets, including protein kinases and transcription factors located in different cellular compartments. Overall, utilizing modular DNA frameworks to conjugate substrates offers a universal platform that not only provides insight into general degrader design principles but also presents a promising strategy for guiding drug discovery. Nature Publishing Group UK 2023-07-27 /pmc/articles/PMC10372072/ /pubmed/37495569 http://dx.doi.org/10.1038/s41467-023-40244-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Zhou, Li
Yu, Bin
Gao, Mengqiu
Chen, Rui
Li, Zhiyu
Gu, Yueqing
Bian, Jinlei
Ma, Yi
DNA framework-engineered chimeras platform enables selectively targeted protein degradation
title DNA framework-engineered chimeras platform enables selectively targeted protein degradation
title_full DNA framework-engineered chimeras platform enables selectively targeted protein degradation
title_fullStr DNA framework-engineered chimeras platform enables selectively targeted protein degradation
title_full_unstemmed DNA framework-engineered chimeras platform enables selectively targeted protein degradation
title_short DNA framework-engineered chimeras platform enables selectively targeted protein degradation
title_sort dna framework-engineered chimeras platform enables selectively targeted protein degradation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372072/
https://www.ncbi.nlm.nih.gov/pubmed/37495569
http://dx.doi.org/10.1038/s41467-023-40244-7
work_keys_str_mv AT zhouli dnaframeworkengineeredchimerasplatformenablesselectivelytargetedproteindegradation
AT yubin dnaframeworkengineeredchimerasplatformenablesselectivelytargetedproteindegradation
AT gaomengqiu dnaframeworkengineeredchimerasplatformenablesselectivelytargetedproteindegradation
AT chenrui dnaframeworkengineeredchimerasplatformenablesselectivelytargetedproteindegradation
AT lizhiyu dnaframeworkengineeredchimerasplatformenablesselectivelytargetedproteindegradation
AT guyueqing dnaframeworkengineeredchimerasplatformenablesselectivelytargetedproteindegradation
AT bianjinlei dnaframeworkengineeredchimerasplatformenablesselectivelytargetedproteindegradation
AT mayi dnaframeworkengineeredchimerasplatformenablesselectivelytargetedproteindegradation